Jiaojiao Yuan1,2
Shuo Qi1,3*
Xufan Zhang1,2Hezheng Lai4Xinyi Li1,2
Chen Xiaoheng1Zhe Li1
Simiao Yao1,2Zhiguo Ding1,3*- 1Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
- 2The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing, China
- 3Sunsimiao Hospital, Beijing University of Chinese Medicine, Tongchuan, Shanxi, China
- 4National Institute of Complementary Medicine, Western Sydney University, Westmead, NSW, Australia
Objective: Hashimoto’s thyroiditis (HT) is the most common type of thyroid disease and can cause many different manifestations. The local symptoms of HT are an under-studied area of research. Therefore, the purpose of this study was to investigate the local symptoms of HT and their prevalence.
Methods: A systematic review was performed to find articles in PubMed that discuss the local symptoms of HT. Relevant vocabulary terms and key terms included: autoimmune thyroid disease (AITD), hyperthyroidism, hypothyroidism, neck, throat, pharynx, airway, esophagus, breathe, swallow, globus, sleep apnea, symptoms, and quality of life. Two investigators independently screened the eligible studies.
Results: A total of 54 articles fulfilled the inclusion criteria. Of these, 25 were clinical studies, 24 were case reports, and five were reviews. These clinical studies and case reports included a total of 2660 HT patients. There were eight local symptoms related to HT: neck pain (0.02%~16%), voice changes (7%~30%), throat discomfort (20%~43.7%), shortness of breath (28%~50%), dysphagia (29%), goiter-related symptoms (69.44%), sleep apnea, and generally defined compressive symptoms. Due to the use of different outcome measures among all the studies, a meta-analysis of the data could not be performed.
Conclusion: Goiter symptoms, which are an item on the ThyPRO scales, are the most frequent local symptoms in HT patients, and include neck pain, voice changes, throat discomfort, and dysphagia. These local symptoms should be identified in the clinic and included in the early diagnosis and management of HT, as well as evaluated further to understand their relevance in the pathogenesis of HT.
1. Introduction
Hashimoto’s thyroiditis (HT) is considered the most common disease among autoimmune thyroid diseases (AITDs), and occurs in approximately 0.3~1.5/1000 subjects/year (1). Pathologically, lymphoplasmacytic infiltration, lymphoid follicle formation with germinal centers, and parenchymal atrophy are typical histopathologic features (2). The pathological diagnosis of HT is based on lymphocytic infiltration on cytological examination (2). Clinically, approximately 25-30% of patients have thyroid dysfunctions (3). Most HT patients with euthyroid or hyperthyroid ultimately evolve into hypothyroidism (3). In most cases, the clinical diagnosis of HT is based on the characteristics, including positivity to serum antibodies against thyroid antigens (thyroid peroxidase and thyroglobulin) (3). The mainstream treatment is focused on the management of hypothyroidism with thyroxine substitution therapy (2).
Generally, the clinical features, which include both local and systemic manifestations of HT, are not typical in patients during the early stage (3). Several articles reported that local manifestations, such as throat problems, dysphagia, neck swelling, and pain, eventually developed when the thyroid gland became enlarged (1). The systemic manifestations were more common in patients with thyroid dysfunction. Patients with hyperthyroidism tended to have palpitations, tremors, heat intolerance, sweating, anxiety, disturbed sleep, weight loss, and polydipsia (4). Patients with hypothyroidism tended to have fatigue, lethargy, cold intolerance, weight gain, constipation, and dry skin (5). There has been a lot of research that focuses on systemic symptoms in patients with thyroid dysfunction. In contrast, the types of local symptoms and their prevalence in HT patients is an under-researched area. This study reviewed the literature to investigate the local symptoms of HT and their prevalence.
2. Methods
2.1. Data sources and searches
A systematic review was performed in PubMed to search for published studies from 1996 to August 28th, 2022. MeSH words, titles, abstracts, and key terms were searched. The search strategy followed was: 1) Hashimoto thyroiditis, autoimmune thyroiditis, autoimmune thyroid disease, hyperthyroidism, thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TGAb), and thyroid microsomal antibody (TMAb); 2) neck, pain, swollen, throat, pharynx, airway, esophagus, breathe, dyspnea, swallow, globus, dysphagia, and sleep apnea; 3) symptoms, sign, manifestation, quality of life, and ThyPRO; 4) 1 AND (2 OR 3).
2.2. Eligibility criteria
Inclusion criteria included clinical trials, case reports, and reviews, with descriptions of specific prevalence or prevalence of local symptoms around HT patients’ neck, including neck, throat, pharynx, airway, esophagus, et al. Studies were excluded that: (a) did not relate to specified search terms in the title or abstract, (b) did not include HT or AITD in the title or abstract, (c) did not illustrate local symptoms of HT in the entire article, (d) were not included in the Science Citation Index (SCI), € publications in languages other than English, and (f) where the full text was unavailable.
2.3. Study selection
Study selection was performed independently by two reviewers (JY and XL). In the first phase, all identified titles and abstracts were evaluated for relevance in thyroid disease. In the second phase, potentially relevant articles were subsequently selected and evaluated through full-text screening. The relevance of the articles in reporting the prevalence or specific prevalence of local symptoms in HT was finally included. In case of a disagreement, a third experienced reviewer (SQ) was consulted to achieve a consensus.
2.4. Data extraction
The following variables in the included studies were extracted: article type, publication date, author, country, region, IF and Quartile of articles, number of cases of HT, age, gender, thyroid function, and prevalence of cases with local symptoms.
3. Results
3.1. Search findings
The PubMed search was performed and initially yielded 8024 records. We excluded 7970 articles through title and abstract, and full-text screening (n = 7769, and n = 201, respectively) (Figure 1).
Figure 1 Flowchart illustrating the results of the literature-search performed in this systematic review.
3.2. Study characteristics
Of the 54 studies included in the review, 25 were clinical studies, 24 were case reports, and five were reviews. After full-text review, it was found that 29 studies mentioned hypothyroidism, five mentioned hyperthyroidism, six mentioned euthyroid, and 15 were unclear about the thyroid function of objects in the articles (Table 1).
Table 1 Study characteristics.
3.3. Distribution of local symptoms
The local symptoms of HT described in all the selected literature were classified into eight categories: neck pain (16 articles), voice changes (11 articles), throat discomfort (eight articles), dyspnea (eight articles), dysphagia (six articles), goiter-related symptoms (seven articles), sleep apnea (six articles), and unclear compressive symptoms (four articles). There were more than two different local symptoms in several studies (Table 2). The prevalence is listed in Figure 2.
Table 2 Distribution of local symptoms.
Figure 2 Prevalence of local symptoms.
3.3.1. Neck pain
There were 10 case reports and four clinical studies included, with a total of 645 HT patients, comprising 456 cases of hypothyroidism, 34 cases of hyperthyroidism, and 52 cases of euthyroid. The prevalence of neck pain in HT patients, especially in hypothyroidism in the clinical studies, was between 0.02% ~ 16% (Table 3).
Table 3 Neck pain.
3.3.2. Voice changes
There were three case reports and eight clinical studies included, with a total of 1005 HT patients, comprising 378 cases of hypothyroidism, zero cases of hyperthyroidism, and 582 cases of euthyroid. The prevalence of voice changes in HT patients across six different regions was between 7% ~ 30% (Table 4).
Table 4 Voice changes.
3.3.3. Throat discomfort
Included were one case report and seven clinical studies, with a total of 393 HT patients, comprising 158 cases of hypothyroidism, zero cases of hyperthyroidism, 49 cases of euthyroid, and 152 cases of unclear thyroid function. The prevalence of throat discomfort in HT patients was between 20%~35% (Table 5).
Table 5 Throat discomfort.
3.3.4. Dyspnea
There were five case reports and three clinical studies included, with a total of 172 HT patients, comprising 168 cases of hypothyroidism, one case of hyperthyroidism, zero cases of euthyroid, and three cases of unclear thyroid function. Two clinical studies from two different regions showed that the occurrence of dyspnea in HT patients was 12.5% ~ 50%. One study presented the prevalence of shortness of breath in HT patients with hypothyroidism at 50% (Table 6).
Table 6 Dyspnea.
3.3.5. Dysphagia
There were four case reports and two clinical studies included, with a total of 169 HT patients, comprising 164 cases of hypothyroidism, one case of hyperthyroidism, and four cases of unclear thyroid function. The prevalence of dysphagia in HT patients with hypothyroidism was 29%. The prevalence of dysphagia in the patients who were prepared to take a thyroidectomy was 33.3% (Table 7).
Table 7 Dysphagia.
3.3.6. Sleep apnea
There were two case reports and four clinical studies included, with a total of 144 HT patients, comprising 16 cases of hypothyroidism, two cases of hyperthyroidism, 106 cases of euthyroid, and four cases of unclear thyroid function. The prevalence of dysphagia in HT patients with hypothyroidism was 29%. However, none of the studies recorded the prevalence of sleep apnea in HT patients (Table 8).
Table 8 Sleep apnea.
3.3.7. Goiter symptoms (ThyPRO scales)
There were eight articles included, and six clinical studies, with a total of 761 HT patients, comprising 736 cases of hypothyroidism, 32 cases of hyperthyroidism, and 74 cases of euthyroid. One article showed the prevalence of goiter symptoms in HT patients was 69.44% (Table 9).
Table 9 Goiter symptoms.
3.3.8. Compressive symptoms
Four clinical studies showed compressive symptoms, but none of these described specific manifestations. A total of 761 HT patients were in these clinical studies, with 736 cases of hypothyroidism, 32 cases of hyperthyroidism, and 74 cases of euthyroid. These studies were limited to HT patients who were to undergo thyroid surgery, and the symptom prevalence was 34%* ~ 72.4%* (Table 10).
Table 10 Compressive symptoms.
4. Discussion
HT is a common thyroid disease with clinical features that include both local and systemic manifestations (3). These manifestations occur not only under the conditions of hypothyroidism or hyperthyroidism but also under euthyroidism (55).
Thyroid-related symptoms are the specific symptoms related to thyroid disease. In past studies, thyroid-related symptoms were initially described as systemic symptoms, such as cold/heat intolerance, dry skin, unexplained hair loss, chronic constipation, recent weight change, fatigue, depression, mood swings, increased stress, and restlessness (58). However, local thyroid-related symptoms were under-studied, with a dearth of systematic review literature that explores this area, especially in HT.
In our review, we specifically examined the local symptoms in HT patients. The percentage of HT patients who experienced goiter symptoms (17), which included symptoms of the neck, throat, breathing, and swallowing, was 69.44%. Goiter symptoms, which mostly resulted in goiter thyroid glands, are important parts of the Thyroid-specific Patient Reported Outcome (ThyPRO) questionnaire. The ThyPRO questionnaire was developed and implemented as the international standard measurement of thyroid-related QoL of patients with benign thyroid diseases. Its reliability, validity, and responsiveness have been extensively documented in many countries (53). In the ThyPRO questionnaire, goiter symptoms are described as the following 11 symptoms: the sensation of fullness in the neck, a visible swelling in front of the neck, pressure in the throat, pain in the throat, pain in the neck, the sensation of a lump in the throat, frequent throat clearing, discomfort swallowing, difficulty swallowing, a sensation of suffocation, and hoarseness. These annoying symptoms can affect the quality of life and mental health of patients with HT to varying degrees (53).
It was reported that 20% ~ 43.7% of HT patients experienced symptoms of throat discomfort (32, 34). Most HT patients with throat symptoms initially attended an ENT clinic. Morinaka (53, 54) found that patients with thyroid disease accounted for about 1.8% of ENT outpatients, and approximately 53.5% of these thyroid disease patients had HT. Therefore, a thyroid examination could be considered necessary for ENT patients and other patients that exhibit symptoms of throat discomfort. Globus is a sensation of having a lump or foreign body in the throat, accounting for approximately 4% of new otorhinolaryngology outpatients (59). In addition to thyroid nodules and enlarged thyroid volume, the inflammation of the thyroid may be another factor reducing uncomfortable throat symptoms (32).
Symptoms of dyspnea were experienced in 28% ~ 50% of HT patients, including chest tightness, wheezing (28%), shortness of breath (50%), and suffocation (16). The difference in the prevalence of the respective specified symptoms is related to the severity of airway obstruction.
Nearly 7% ~ 30% of HT patients experienced voice changes, which included voice deepening, hoarseness, and dysphonia (16–18). Approximately 29% of HT patients experienced dysphagia (16). Immuno-mediated diseases may affect the laryngeal function and vocal fold vibration through multi-factorial mechanisms, while dysphonia or dysphagia may be the first sign of an autoimmune disease (60). Galli (60) investigated the prevalence and severity of dysphonia, globus pharynges, and dysphagia in patients affected by immune-mediated (IM) diseases by the Voice Handicap Index (VHI) (scale 0-4) and Glasgow-Edinburgh Throat Scale (GETS). The self-assessment questionnaires could be considered a useful tool for early detection of vocal dysfunction in HT patients, to prevent further deterioration of quality of life and serious life-threatening complications (61).
It was discovered that 0.02% ~ 16% of HT patients experienced pain in the front of their neck (7, 16, 17). Painful Hashimoto thyroiditis (pHT) is an atopic subtype of HT characterized by acute, progressive, unbearable pain on one side or the entire thyroid area (19). Some hypotheses suggested that pHT is caused by capsular stretching with rapid enlargement of the thyroid (13). However, pain could also emerge in atrophic thyroid glands and other thyroid-disease patients, such as in DeQuervain thyroiditis, acute suppurative thyroiditis, hemorrhage in the thyroid nodule, and in the rapid growth of the thyroid tumor (19), making it necessary for a differential diagnosis.
Most local manifestations originate from compression of the cervical structures that are anatomically close to the thyroid gland, and include dysphonia (from the involvement of the recurrent laryngeal nerve), dyspnea (from the restriction of the trachea), and dysphagia (from impingement upon the esophagus) (3). Therefore, several studies considered that HT patients with aggressive compressive symptoms, such as dyspnea, dysphagia, unrelievable pain, and globus, could experience relief after a thyroidectomy (11, 18). A few studies suspected that the immune disorder may be a risk factor for local manifestations (55, 60).
Several studies found that there is a certain correlation between levels of thyroid-related antibodies and the occurrence of local symptoms. Watt et al. (53) found a positive correlation between TPOAb and goiter symptoms (p=0.019, r=0.17). Other studies suggested that TPOAb levels are associated with an increased prevalence of airflow limitation or asthma (62). However, there is a lack of studies that indicate whether a relief of goiter symptoms occurs after effective treatment to decrease TPOAb.
In addition to the above symptoms, there are also some changes in local signs, such as goiter (enlarged neck and disappearance of necklines), and enlarged cervical lymph nodes. Some studies found that the prevalence of cervical lymphadenopathy in patients with positive TPOAb or TGAb is approximately 63% ~ 88.5% (63–65), and they suggested that cervical lymphadenopathy may be one of the indicators to distinguish thyroiditis from other benign thyroid diseases.
From the 54 studies in our review, local manifestations were usually ignored in the clinic and research. However, they could affect the quality of life and mental health of HT patients. According to the literature, a thyroidectomy is an option to relieve the aggressive compressed symptoms. However, the necessity of surgical treatment remains to be discussed. Thus, diversified treatment methods to improve local manifestations could play an important role in the management of HT and in delaying the process of hypothyroidism.
5. Limitations
There were some limitations identified in this review. First, this review included clinical research and case reports that discussed the differences in local symptoms between HT patients and patients suffering from other benign thyroid diseases. Thus, these findings may not reflect the real-world prevalence of these local symptoms in HT patients. Second, most symptoms in the research were subjective and lacked certain definitions. Third, this review also included some cross-sectional studies that focused on one or two of these local symptoms and the results of which cannot be representative of the comprehensive local symptoms of HT. Lastly, this review included some studies of HT patients who were prepared to undertake a thyroidectomy or had hypothyroidism, which may create bias in the prevalence of the local symptoms. Therefore, our findings of the prevalence of local symptoms through this review are considered as an initial basis for reference, and a more extensive and in-depth cross-sectional investigation is needed to clarify the epidemiological characteristics of local symptoms of HT.
6. Conclusions
HT patients do experience local symptoms, such as pain, voice changes, throat discomfort, dyspnea, dysphagia, and sleep apnea. The goiter symptoms in the ThyPRO scales include most of these local symptoms, and thus the ThyPRO is a good questionnaire to evaluate the symptoms of HT. At present, HT patients with aggressive compressive symptoms have been recommended for a thyroidectomy in some studies. The necessity of surgical treatment remains to be discussed. The presentation of local symptoms of HT should be identified in clinics for improvement in the detection and early diagnosis and management of HT, as well as evaluated further to understand their relevance in the pathogenesis of HT.
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
Shanxi Administration of Traditional Chinese Medicine, 2021-GJ-LC001.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C, et al. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab (2019) 33(6):101367. doi: 10.1016/j.beem.2019.101367
2. Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, et al. Hashimoto’s thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev (2020) 19(10):102649. doi: 10.1016/j.autrev.2020.102649
3. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev (2014) 13(4-5):391–7. doi: 10.1016/j.autrev.2014.01.007
4. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet (2016) 388(10047):906–18. doi: 10.1016/S0140-6736(16)00278-6
5. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet (2017) 390(10101):1550–62. doi: 10.1016/S0140-6736(17)30703-1
6. Ichijo M, Tsuchiya K, Kasai T, Inoshita N, Yoshimoto H, Yamada S, et al. Follicle-stimulating hormone-secreting pituitary adenoma accompanied by painful thyroiditis. Intern Med (2020) 59(4):545–50. doi: 10.2169/internalmedicine.3667-19
7. Krakovitz P, Cairns C, Schweiger BM, Burkey B. Surgical management of neck pain and headache associated with pediatric hashimoto’s thyroiditis. Laryngoscope (2018) 128(9):2213–7. doi: 10.1002/lary.27099
8. Tamborini Permunian E, Mumoli N, Callegari L, Tragni CM, Ageno W. An unusual case of neck pain in hashimoto’s thyroiditis. Intern Emerg Med (2017) 12(6):817–9. doi: 10.1007/s11739-017-1686-9
9. Visser R, de Mast Q, Netea-Maier RT, van der Ven AJAM. Hashimoto’s thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus-seropositive patient. Thyroid (2012) 22(8):853–5. doi: 10.1089/thy.2012.0055
10. Ohye H, Nishihara E, Sasaki I, Kubota S, Fukata S, Amino N, et al. Four cases of graves’ disease which developed after painful hashimoto’s thyroiditis. Intern Med (2006) 45(6):385–9. doi: 10.2169/internalmedicine.45.1506
11. Kon YC, DeGroot LJ. Painful hashimoto’s thyroiditis as an indication for thyroidectomy: clinical characteristics and outcome in seven patients. J Clin Endocrinol Metab (2003) 88(6):2667–72. doi: 10.1210/jc.2002-021498
12. Konno S, Konno N, Yokobori M, Kazui K, Hase T, Uematsu T, et al. Autoimmune thyroid disease accompanied by recurring episodes of painful thyroid ameliorated by thyroidectomy. J Endocrinol Invest. (2002) 25(11):996–1000. doi: 10.1007/BF03344075
13. Gourgiotis L, Al-Zubaidi N, Skarulis MC, Papanicolaou DA, Libutti SK, Alexander HR Jr, et al. Successful outcome after surgical management in two cases of the “painful variant” of hashimoto’s thyroiditis. Endocr Pract (2002) 8(4):259–65. doi: 10.4158/EP.8.4.259
14. Shigemasa C, Ueta Y, Mitani Y, Taniguchi S, Urabe K, Tanaka T, et al. Chronic thyroiditis with painful tender thyroid enlargement and transient thyrotoxicosis. J Clin Endocrinol Metab (1990) 70(2):385–90. doi: 10.1210/jcem-70-2-385
15. Leung AK, Hegde K. Autoimmune thyroiditis presenting as painful thyroiditis. Eur J Pediatr (1989) 149(2):146. doi: 10.1007/BF01995872
16. Carlé A, Karmisholt JS, Knudsen N, Perrild H, Thuesen BH, Ovesen L, et al. Does subclinical hypothyroidism add any symptoms? evidence from a Danish population-based study. Am J Med (2021) 134(9):1115–1126.e1. doi: 10.1016/j.amjmed.2021.03.009
17. Thomas T, Sreedharan S, Khadilkar UN, Deviprasad D, Kamath MP, Bhojwani KM, et al. Clinical, biochemical & cytomorphologic study on hashimoto’s thyroiditis. Indian J Med Res (2014) 140(6):729–35.
18. Shih ML, Lee JA, Hsieh CB, Yu JC, Liu HD, Kebebew E, et al. Thyroidectomy for hashimoto’s thyroiditis: complications and associated cancers. Thyroid (2008) 18(7):729–34. doi: 10.1089/thy.2007.0384
19. Rotondi M, Capelli V, Locantore P, Pontecorvi A, Chiovato L. Painful hashimoto’s thyroiditis: myth or reality? J Endocrinol Invest (2017) 40(8):815–8. doi: 10.1007/s40618-017-0655-5
20. Kasagi K. Painful hashimoto’s thyroiditis. Intern Med (2006) 45(6):351–2. doi: 10.2169/internalmedicine.45.0144
21. Kotwal SK, Kotwal S, Gupta R, Singh JB, Mahajan A. Cerebellar ataxia as presenting feature of hypothyroidism. Arch Endocrinol Metab (2016) 60(2):183–5. doi: 10.1590/2359-3997000000121
22. Maselli M, Inelmen EM, Giantin V, Manzato E. Hypothyroidism in the elderly: diagnostic pitfalls illustrated by a case report. Arch Gerontol Geriatr. (2012) 55(1):82–4. doi: 10.1016/j.archger.2011.05.003
23. Hosako-Naito Y, Tayama N, Niimi S, Aotsuka S, Miyaji M, Oka T, et al. Diagnosis and physiopathology of laryngeal deposits in autoimmune disease. ORL J Otorhinolaryngol Relat Spec. (1999) 61(3):151–7. doi: 10.1159/000027661
24. Barić A, Brčić L, Gračan S, Škrabić V, Brekalo M, Šimunac M, et al. Thyroglobulin antibodies are associated with symptom burden in patients with hashimoto’s thyroiditis: A cross-sectional study. Immunol Invest. (2019) 48(2):198–209. doi: 10.1080/08820139.2018.1529040
25. Lima Carvalho M de F, de Medeiros JS, Valença MM. Headache in recent onset hypothyroidism: Prevalence, characteristics and outcome after treatment with levothyroxine. Cephalalgia (2017) 37(10):938–46. doi: 10.1177/0333102416658714
26. Rhee SJ, Hong HS, Kim CH, Lee EH, Cha JG, Jeong SH. Using acoustic structure quantification during b-mode sonography for evaluation of hashimoto thyroiditis. J Ultrasound Med (2015) 34(12):2237–43. doi: 10.7863/ultra.14.11077
27. Banks CA, Ayers CM, Hornig JD, Lentsch EJ, Day TA, Nguyen SA, et al. Thyroid disease and compressive symptoms. Laryngoscope (2012) 122(1):13–6. doi: 10.1002/lary.22366
28. McManus C, Luo J, Sippel R, Chen H. Should patients with symptomatic hashimoto’s thyroiditis pursue surgery? J Surg Res (2011) 170(1):52–5. doi: 10.1016/j.jss.2011.01.037
29. Heman-Ackah YD, Joglekar SS, Caroline M, et al. The prevalence of undiagnosed thyroid disease in patients with symptomatic vocal fold paresis. J Voice (2011) 25(4):496–500. doi: 10.1016/j.jvoice.2010.03.008
30. Kamienski M. When sore throat gets serious: three different cases, three very different causes. Am J Nurs. (2007) 107(10):35–8. doi: 10.1097/01.NAJ.0000292195.68453.67
31. Fukuhara T, Matsuda E, Ogawa A, Donishi R, Koyama S, Fujiwara K. Use of cervical ultrasonography in globus sensation investigation: A retrospective cohort study. Yonago Acta Med (2021) 64(4):360–3. doi: 10.33160/yam.2021.11.007
32. Karahatay S, Ayan A, Aydin U, Ince S, Emer O, Alagoz E. The increased risk of globus pharyngeus in patients with chronic thyroiditis: a case control study. Eur Rev Med Pharmacol Sci (2015) 19(24):4722–7.
33. Greenblatt DY, Sippel R, Leverson G, Frydman J, Schaefer S, Chen H. Thyroid resection improves perception of swallowing function in patients with thyroid disease. World J Surg (2009) 33(2):255–60. doi: 10.1007/s00268-008-9837-9
34. Bazzichi L, Rossi A, Giuliano T, De Feo F, Giacomelli C, Consensi A, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol (2007) 26(12):2115–20. doi: 10.1007/s10067-007-0636-8
35. Grabe HJ, Völzke H, Lüdemann J, Wolff B, Schwahn C, John U, et al. Mental and physical complaints in thyroid disorders in the general population. Acta Psychiatr Scand (2005) 112(4):286–93. doi: 10.1111/j.1600-0447.2005.00586.x
36. Gong PH, Dong XS, Li C, Bao J, Cao ZL, Yuan Y, et al. Acute severe asthma with thyroid crisis and myasthenia: a case report and literature review. Clin Respir J (2017) 11(6):671–6. doi: 10.1111/crj.12403
37. Mohamed M, Fernando R, Arora A. Airway obstruction after the development of hashimoto’s thyroiditis. BMJ (2014) 348:g1643. doi: 10.1136/bmj.g1643
38. Vargas N, Tibullo L, Carifi S, Cucciniello A, Landi E, Barbella MR, et al. Type 2 respiratory failure and falls in elderly adults: beware of the thyroid! J Am Geriatr Soc (2014) 62(10):2026–7. doi: 10.1111/jgs.13041
39. Reynolds BC, Simpson JH, Macara L, Watt AJ, Kubba H, Donaldson MD, et al. Goitrous congenital hypothyroidism in a twin pregnancy causing respiratory obstruction at birth: implications for management. Acta Paediatr (2006) 95(11):1345–8. doi: 10.1080/08035250600711074
40. Laurent S, Mouthon L, Longchampt E, Roudaire M, Franc S, Krivitzky A, et al. Medical cure of plasma cell granuloma of the thyroid associated with hashimoto’s thyroiditis: a case report and review. J Clin Endocrinol Metab (2004) 89(4):1534–7. doi: 10.1210/jc.2003-031355
41. Liang Z, Long F, Deng K, Wang F, Xiao J, Yang Y, et al. Dissociation between airway and systemic autoantibody responses in chronic obstructive pulmonary disease. Ann Transl Med (2020) 8(15):918. doi: 10.21037/atm-20-944
42. Guldiken B, Guldiken SS, Turgut N, Yuce M, Arikan E, Tugrul A. Dysphagia as a primary manifestation of hyperthyroidism: a case report. Acta Clin Belg. (2006) 61(1):35–7. doi: 10.1179/acb.2006.007
43. Pereira FO, Graf H, Nomura LM, Neto JZ, Collaço LM, Boguszewski CL. Concomitant presentation of hashimoto’s thyroiditis and maltoma of the thyroid in a twenty-year-old man with a rapidly growing mass in the neck. Thyroid (2000) 10(9):833–5. doi: 10.1089/thy.2000.10.833
44. Shawker TH, Paling MR, Weintraub B. Dysphagia due to thyroid immobilization: value of real-time sonography. AJR Am J Roentgenol. (1981) 136(3):601–2. doi: 10.2214/ajr.136.3.601
45. Eloy JA, Omerhodzic S, Som PM, Genden EM. Goitrous hashimoto’s thyroiditis presenting as obstructive sleep apnea. Thyroid (2007) 17(7):691–2. doi: 10.1089/thy.2006.0250
46. Stöllberger C, Finsterer J, Brand E, Tschabitscher D. Dysarthria as the leading symptom of hypothyroidism. Am J Otolaryngol (2001) 22(1):70–2. doi: 10.1053/ajot.2001.20698
47. Sriphrapradang C, Pinyopodjanard S, Suntornlohanakul O, Nimitphong H, Chirakalwasan N, Saetang S, et al. Lack of associations between thyroid function and obstructive sleep apnea severity in adults with prediabetes and diabetes mellitus. Sleep Breath (2019) 23(3):963–7. doi: 10.1007/s11325-018-1756-x
48. Bozkurt NC, Karbek B, Cakal E, Firat H, Ozbek M, Delibasi T. The association between severity of obstructive sleep apnea and prevalence of hashimoto’s thyroiditis. Endocr J (2012) 59(11):981–8. doi: 10.1507/endocrj.ej12-0106
49. Xerfan EMS, Facina AS, Andersen ML, Tufik S, Tomimori J. Hashimoto thyroiditis as a cause or consequence of obstructive sleep apnea. J Clin Sleep Med (2019) 15(11):1703. doi: 10.5664/jcsm.8054
50. Morón-Díaz M, Saavedra P, Alberiche-Ruano MP, Rodríguez-Pérez CA, López-Plasencia Y, Marrero-Arencibia D, et al. Correlation between TSH levels and quality of life among subjects with well-controlled primary hypothyroidism. Endocrine (2021) 72(1):190–7. doi: 10.1007/s12020-020-02449-4
51. Winther KH, Cramon P, Watt T, Bjorner JB, Ekholm O, Feldt-Rasmussen U, et al. Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PloS One (2016) 11(6):e0156925. doi: 10.1371/journal.pone.0156925
52. Zivaljevic VR, Bukvic Bacotic BR, Sipetic SB, Stanisavljevic DM, Maksimovic JM, Diklic AD, et al. Quality of life improvement in patients with hashimoto thyroiditis and other goiters after surgery: A prospective cohort study. Int J Surg (2015) 21:150–5. doi: 10.1016/j.ijsu.2015.08.001
53. Watt T, Groenvold M, Hegedüs L, Bonnema SJ, Rasmussen ÅK, Feldt-Rasmussen U, et al. Few items in the thyroid-related quality of life instrument ThyPRO exhibited differential item functioning. Qual Life Res (2014) 23(1):327–38. doi: 10.1007/s11136-013-0462-1
54. Watt T, Hegedüs L, Bjorner JB, Groenvold M, Bonnema SJ, Rasmussen AK, et al. Is thyroid autoimmunity per se a determinant of quality of life in patients with autoimmune hypothyroidism? Eur Thyroid J (2012) 1(3):186–92. doi: 10.1159/000342623
55. Groenewegen KL, Mooij CF, van Trotsenburg ASP. Persisting symptoms in patients with hashimoto’s disease despite normal thyroid hormone levels: Does thyroid autoimmunity play a role? a systematic review. J Transl Autoimmun (2021) 4:100101. doi: 10.1016/j.jtauto.2021.100101
56. Feller M, Snel M, Moutzouri E, Bauer DC, de Montmollin M, Aujesky D, et al. Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: A systematic review and meta-analysis. JAMA (2018) 320(13):1349–59. doi: 10.1001/jama.2018.13770
57. Wormer BA, McHenry CR. Hashimoto’s thyroiditis: outcome of surgical resection for patients with thyromegaly and compressive symptoms. Am J Surg (2011) 201(3):416–9. doi: 10.1016/j.amjsurg.2010.08.021
58. Hedman C, Djärv T, Strang P, Lundgren CI. Effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma: A population-based study in Sweden. Thyroid (2017) 27(8):1034–42. doi: 10.1089/thy.2016.0604
59. Moloy PJ, Charter R. The globus symptom. incidence, therapeutic response, and age and sex relationships. Arch Otolaryngol (1982) 108(11):740–4. doi: 10.1001/archotol.1982.00790590062017
60. Galli J, Marchese MR, De Canio C, et al. The prevalence of dysphonia and dysphagia in patients affected by immunomediated diseases and the role of psychometric tests. Clin Rheumatol (2019) 38(1):77–84. doi: 10.1007/s10067-018-4129-8
61. Morinaka S. On the frequency of thyroid diseases in outpatients in an ENT clinic. Auris Nasus Larynx. (1995) 22(3):186–91. doi: 10.1016/s0385-8146(12)80057-5
62. Samareh Fekri M, Shokoohi M, Gozashti MH, Esmailian S, Jamshidian N, Shadkam-Farokhi M, et al. Association between anti-thyroid peroxidase antibody and asthma in women. Iran J Allergy Asthma Immunol (2012) 11(3):241–5. doi: 10.1007/s10067-018-4129-8
63. Örmeci T, Çolakoğulları M, Orhan İ, Şakul BU. Importance of sonographic paratracheal lymph node evaluationin early autoimmune thyroiditis. Turk J Med Sci (2016) 46(6):1862–70. doi: 10.3906/sag-1511-95
64. Lyu GR, Zheng WK, Lin WL, Zheng LP, Guo HX, Li LY. Sonographic features of cervical lymph nodes in patients with hashimoto thyroiditis and the impacts from the levothyroxine with prednisone therapy. Ultrasound Q (2018) 34(2):67–70. doi: 10.1097/RUQ.0000000000000324
Keywords: Hashimoto’s thyroiditis, symptoms, prevalence, quality of life, hypothyroidism
Citation: Yuan J, Qi S, Zhang X, Lai H, Li X, Xiaoheng C, Li Z, Yao S and Ding Z (2023) Local symptoms of Hashimoto’s thyroiditis: A systematic review. Front. Endocrinol. 13:1076793. doi: 10.3389/fendo.2022.1076793
Received: 22 October 2022; Accepted: 22 December 2022;
Published: 19 January 2023.
Edited by:
Joseph V Martin, Rutgers University Camden, United StatesReviewed by:
Ramakanth Bhargav Panchangam, BGH (Bhargav Endocrine Hospital), IndiaYu Sun, Qilu Hospital, Shandong University, China
Copyright © 2023 Yuan, Qi, Zhang, Lai, Li, Xiaoheng, Li, Yao and Ding. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shuo Qi, c2h1b3FpQGJ1Y20uZWR1LmNu; Zhiguo Ding, ZGluZ3poaWd1b18xQDE2My5jb20=